Search

Author/Creator Chen, Can‐Ming

1. Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial. Issue 13 (20th March 2019)

Authors:
Yu, Ke‐Da; Wu, Si‐Yu; Liu, Guang‐Yu; Wu, Jiong; Di, Gen‐Hong; Hu, Zhen; Hou, Yi‐Feng; Chen, Can‐Ming; Fan, Lei; Tang, Li‐Chen; Shen, Zhen‐Zhou; Wu, Ke‐Jin; Zhuang, Zhi‐Gang; Zhang, Hong‐Wei; Shao, Zhi‐Ming
Journal:
Cancer
Issue:
Volume 125:Issue 13(2019)
Page Start:
2185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Weekly Paclitaxel/Carboplatin/Trastuzumab Therapy Improves Pathologic Complete Remission in Aggressive HER2‐Positive Breast Cancers, Especially in Luminal‐B Subtype, Compared With a Once‐Every‐3‐Weeks Schedule. (1st May 2013)

Authors:
Yu, Ke‐Da; Liu, Guang‐Yu; Chen, Can‐Ming; Li, Jian‐Wei; Wu, Jiong; Lu, Jin‐Song; Shen, Zhen‐Zhou; Shao, Zhi‐Ming
Journal:
Oncologist
Issue:
Volume 18:Number 5(2013)
Page Start:
511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗